ICU SeaStar Medical Holding Corporation

P/E --
Forward P/E --
Price/Sales 6.8
Beta -1.044
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ SeaStar Medical is trading 10.5% down in pre-market

SeaStar Medical is trading at $1.79, down 10.50% in pre-market, with no specific negative company catalyst identified in available reporting. - On November 3,...

πŸ”΄ SeaStar Medical is trading 12.3% down β€” no specific negative catalyst identified

SeaStar Medical is trading at $1.92, down 12.33%, with no specific negative catalyst identified in available reporting. - On November 3, 2026, the FDA...

SeaStar Medical Fulfills FDA Post-Approval Study Requirements for QUELIMMUNE Therapy

SeaStar Medical Fulfills FDA Post-Approval Study Requirements for QUELIMMUNE Therapy

SeaStar Medical announced that the U.S. Food and Drug Administration (FDA) has confirmed the company has fulfilled its post-approval study requirements for the...

πŸ”΄ SeaStar Medical is trading 5% down with no clear catalyst identified

SeaStar Medical is trading at $2.08, down -5.02%, with no identified explanation for the decline. - As of 11:38 a.m. EST on November 3, 2026; the provided...

🟒 SeaStar Medical is trading 11% up today after FDA confirms QUELIMMUNE study completion

SeaStar Medical is trading up 10.96% at $2.43 after the FDA confirmed on November 3, 2026, that the required post-approval study for its pediatric QUELIMMUNE...

SeaStar Medical Clears a Key FDA Hurdle for Its Pediatric Kidney Therapy β€” But Can a $12 Million Company Turn Wider Hospital Access Into Real Revenue?

SeaStar Medical Clears a Key FDA Hurdle for Its Pediatric Kidney Therapy β€” But Can a $12 Million Company Turn Wider Hospital Access Into Real Revenue?

Shares of SeaStar Medical (ICU) surged +10.5% to $2.42 after the FDA confirmed the company has satisfied all post-approval study requirements for its pediatric...

🟒 SeaStar Medical is trading 10.5% up in pre-market after FDA confirms QUELIMMUNE post-approval study completion

SeaStar Medical is trading at $2.42 (+10.51%) after the FDA confirmed fulfillment of QUELIMMUNE’s required post-approval study. - On November 3, 2026,...

πŸ”΄ SeaStar Medical is trading 5.8% down on October 30, 2026 with no clear catalyst identified

SeaStar Medical is trading at $2.14, down 5.84%, on October 30, 2026, with no specific reason for the decline established. - No clear company-specific...

πŸ”΄ SeaStar Medical is trading 5% down; no clear catalyst identified

SeaStar Medical is trading at $2.35, down 5.24%, as no clear catalyst for the October 29 decline surfaced in the sources reviewed. - The latest identified...

πŸ”΄ SeaStar Medical is trading 11.4% down today with no confirmed company-specific cause

SeaStar Medical is trading at $2.52, down -11.40%, with no confirmed company-specific explanation for the October 23 decline. - Positive pediatric registry...

πŸ”΄ SeaStar Medical is trading 6% down today amid healthcare weakness, with cause unconfirmed

SeaStar Medical is trading 6% down at $2.68 on October 23, 2026; healthcare weakness is a possible backdrop, but no direct cause is established. - Healthcare...

πŸ”΄ SeaStar Medical is trading 7.6% down amid broader market pressure

SeaStar Medical is trading at $2.93, down 7.57%, with no clear company-specific explanation; broader market pressure is the likelier context. - On October 22,...

🟒 SeaStar Medical is trading 6.2% up today with broader healthcare strength a possible factor

SeaStar Medical is trading at $3.08, up 6.20% in live trading, with no clear company-specific catalyst identified for the October 19 move. - The latest...

πŸ”΄ SeaStar Medical is trading 5% down today amid market weakness; no direct catalyst confirmed

SeaStar Medical is trading at $2.90, down 5.23%, with broad market weakness the likeliest available context, not a confirmed catalyst. - Current coverage...

πŸ”΄ SeaStar Medical is trading 10.72% down on October 14, 2026 with no confirmed company-specific catalyst

SeaStar Medical is trading at $3.21, down 10.72%, with no confirmed company-specific catalyst explaining the decline. - The October 14 announcement concerned...

πŸ”΄ SeaStar Medical is trading 6.4% down

SeaStar Medical is trading 6.4% lower at $3.36, with no identified company-specific announcement or confirmed catalyst explaining the October 14, 2026...

πŸ”΄ SeaStar Medical is trading 5.3% down in pre-market with no clear catalyst identified

SeaStar Medical is trading 5.3% lower at $3.40 in pre-market, with no direct company or market catalyst established. - Shares declined 6.75% to $3.59 on...

πŸ”΄ SeaStar Medical is trading 8.1% down today β€” no clear catalyst identified

SeaStar Medical is trading 8.1% lower at $3.54, with no clear company-specific announcement identified to explain the October 13 move. - The broader market...

🟒 SeaStar Medical is trading 5.8% up today with no confirmed catalyst

SeaStar Medical is trading up 5.82% at $3.82, with no confirmed catalyst identified for the October 12, 2026 move. - The latest notable company news was the...

🟒 SeaStar Medical is trading 5.73% up in pre-market with no confirmed catalyst

SeaStar Medical is trading at $3.69, up 5.73% in pre-market; no confirmed catalyst for October 9 was identified. - The latest major company news was the FDA’s...